Combined targeted DNA sequencing in Non-Small Cell Lung Cancer (NSCLC) using UNCseq and NGScopy, and RNA sequencing using UNCqeR for the detection of genetic aberrations in NSCLC

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Zhao, Xiaobei ^a   Wang, Anyou ^a   Walter, Vonn ^a   Patel, Nirali M ^a,b   Eberhard, David A ^a,b   Hayward, Michele C ^a   Salazar, Ashley H ^a   Jo, Heejoon ^a,c   Soloway, Matthew G ^a   Wilkerson, Matthew D ^a,b   Parker, Joel S ^a   Yin, Xiaoying ^a   Zhang, Guosheng ^a   Siegel, Marni B ^b   Rosson, Gary B ^a,b   Earp, H Shelton ^a,b   Sharpless, Norman E ^a,b   Gulley, Margaret L ^a,b   Weck, Karen E ^a,b   Hayes, D Neil ^a,b   Moschos, Stergios J ^a,b   more..

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c The University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; B RAF KINASE; BRG1 PROTEIN; CBL PROTEIN; FIBROBLAST GROWTH FACTOR RECEPTOR 3; HLA A ANTIGEN; KELCH LIKE ECH ASSOCIATED PROTEIN 1; NOTCH1 RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; PROTEIN KINASE LKB1; PROTEIN P53; SMAD4 PROTEIN; VASCULOTROPIN RECEPTOR; KRAS PROTEIN, HUMAN; PROTEIN P21;

ADULT; AGED; ALGORITHM; ARID1A GENE; ARTICLE; ATM GENE; BRAF GENE; BRD3 GENE; CANCER GRADING; CANCER STAGING; CBL GENE; COHORT ANALYSIS; CONTROLLED STUDY; COPY NUMBER VARIATION; CTNNB1 GENE; DNA SEQUENCE; EGFR GENE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FBXW7 GENE; FEMALE; FGFR3 GENE; GENE; GENE DISRUPTION; GENETIC PARAMETERS; GOPC GENE; HLA A GENE; HUMAN; HUMAN TISSUE; KEAP1 GENE; KIAA0427 GENE; MAJOR CLINICAL STUDY; MALE; MLL2 GENE; NEXT GENERATION SEQUENCING; NF1 GENE; NFE2L2 GENE; NON SMALL CELL LUNG CANCER; NOTCH1 GENE; ONCOGENE K RAS; PIK3CA GENE; PPP2R1A GENE; PTEN GENE; RB1 GENE; RBM10 GENE; RNA SEQUENCE; SANGER SEQUENCE; SENSITIVITY AND SPECIFICITY; SETD2 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE NUCLEOTIDE VARIATION; SMAD4 GENE; SMARCA4 GENE; STK11 GENE; TP53 GENE; U2AF1 GENE; BIOLOGY; GENETIC ASSOCIATION STUDY; GENETIC VARIATION; GENETICS; GENOMICS; HIGH THROUGHPUT SEQUENCING; LUNG TUMOR; MIDDLE AGED; MUTATION; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; COMPUTATIONAL BIOLOGY; DNA COPY NUMBER VARIATIONS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; NEOPLASM GRADING; NEOPLASM STAGING; PROTO-ONCOGENE PROTEINS P21(RAS); REPRODUCIBILITY OF RESULTS;

EID: 84953897271     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0129280     Document Type: Article

References (62)

1. Cottrell CE, Al-Kateb H, Bredemeyer AJ, Duncavage EJ, Spencer DH, Abel HJ, et al. Validation of a next-generation sequencing assay for clinical molecular oncology. J Mol Diagn. 2014; 16: 89-105. doi: 10.1016/j.jmoldx.2013.10.002 PMID: 24211365
2. Collins FS, Hamburg MA: First FDA authorization for next-generation sequencer. N Engl J Med. 2013; 369: 2369-2371. doi: 10.1056/NEJMp1314561 PMID: 24251383
3. Frampton GM, Fichtenholtz A, Otto GA, Wang K, Downing SR, He J, et al. Nat Biotechnol. 2013; 31: 1023-1031. doi: 10.1038/nbt.2696 PMID: 24142049
4. Jour G, Scarborough JD, Jones RL, Loggers E, Pollack SM, Pritchard CC, et al. Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeutics. Hum Pathol. 2014; 45: 1563-1571. doi: 10.1016/j.humpath.2014.04.012 PMID: 24908143
5. Garralda E, Paz K, Lopez-Casas PP, Jones S, Katz A, Kann LM, et al. Integrated next-generation sequencing and avatar mouse models for personalized cancer treatment. Clin Cancer Res. 2014; 20: 2476-2484. doi: 10.1158/1078-0432.CCR-13-3047 PMID: 24634382
6. Singh RR, Patel KP, Routbort MJ, Aldape K, Lu X, Manekia J, et al. Clinical massively parallel next-generation sequencing analysis of 409 cancer-related genes for mutations and copy number variations in solid tumours. Br J Cancer. 2014; 111: 2014-2023. doi: 10.1038/bjc.2014.518 PMID: 25314059
7. Choudhary A, Mambo E, Sanford T, Boedigheimer M, Twomey B, Califano J, et al. Evaluation of an integrated clinical workflow for targeted next-generation sequencing of low-quality tumor DNA using a 51-gene enrichment panel. BMC Med Genomics. 2014; 7: 62. doi: 10.1186/s12920-014-0062-0 PMID: 25395014
8. Hagemann IS, Devarakonda S, Lockwood CM, Spencer DH, Guebert K, Bredemeyer AJ, et al. Clinical next-generation sequencing in patients with non-small cell lung cancer. Cancer. 2015; 121: 631-639. doi: 10.1002/cncr.29089 PMID: 25345567
9. Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, Beare D, et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res. 2011; 39: D945-950. doi: 10.1093/nar/gkq929 PMID: 20952405
10. Hsu F, Kent WJ, Clawson H, Kuhn RM, Diekhans M, Haussler D: The UCSC Known Genes. Bioinformatics. 2006; 22: 1036-1046. PMID: 16500937
11. Rhead B, Karolchik D, Kuhn RM, Hinrichs AS, Zweig AS, Fujita PA, et al. The UCSC Genome Browser database: update 2010. Nucleic Acids Res. 2010; 38: D613-619. doi: 10.1093/nar/gkp939 PMID: 19906737
12. Mardis ER: Next-generation DNA sequencing methods. Annu Rev Genomics Hum Genet. 2008; 9: 387-402. doi: 10.1146/annurev.genom.9.081307.164359 PMID: 18576944
13. Cock PJ, Fields CJ, Goto N, Heuer ML, Rice PM: The Sanger FASTQ file format for sequences with quality scores, and the Solexa/Illumina FASTQ variants. Nucleic Acids Res. 2010; 38: 1767-1771. doi: 10.1093/nar/gkp1137 PMID: 20015970
14. Li H, Durbin R: Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009; 25: 1754-1760. doi: 10.1093/bioinformatics/btp324 PMID: 19451168
15. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009; 25: 2078-2079. doi: 10.1093/bioinformatics/btp352 PMID: 19505943
16. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010; 20: 1297-1303. doi: 10.1101/gr.107524.110 PMID: 20644199
17. Mose LE, Wilkerson MD, Hayes DN, Perou CM, Parker JS: ABRA: improved coding indel detection via assembly-based realignment. Bioinformatics. 2014; 30: 2813-2815. doi: 10.1093/bioinformatics/btu376 PMID: 24907369
18. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods. 2008; 5: 621-628. doi: 10.1038/nmeth.1226 PMID: 18516045
19. Gerstung M, Beisel C, Rechsteiner M, Wild P, Schraml P, Moch H, et al. Reliable detection of subclonal single-nucleotide variants in tumour cell populations. Nat Commun. 2012; 3: 811-811. doi: 10.1038/ncomms1814 PMID: 22549840
20. Lee J, van Hummelen P, Go C, Palescandolo E, Jang J, Park HY, et al. High-throughput mutation profiling identifies frequent somatic mutations in advanced gastric adenocarcinoma. PLoS One. 2012; 7: e38892. doi: 10.1371/journal.pone.0038892 PMID: 22723903
21. Cornfield J: A method of estimating comparative rates from clinical data; applications to cancer of the lung, breast, and cervix. J Natl Cancer Inst. 1951; 11: 1269-1275. PMID: 14861651
22. Li H, Glusman G, Hu H, Shankaracharya, Caballero J, Hubley R, et al. Relationship estimation from whole-genome sequence data. PLoS Genet. 2014; 10: e1004144. doi: 10.1371/journal.pgen.1004144 PMID: 24497848
23. Chen X, Bahrami A, Pappo A, Easton J, Dalton J, Hedlund E, et al. Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma. Cell Rep. 2014; 7: 104-112. doi: 10.1016/j.celrep.2014.03.003 PMID: 24703847
24. Jeck WR, Parker J, Carson CC, Shields JM, Sambade MJ, Peters EC, et al. Targeted next generation sequencing identifies clinically actionable mutations in patients with melanoma. Pigment Cell Melanoma Res. 2014; 27: 653-663. doi: 10.1111/pcmr.12238 PMID: 24628946
25. Jayaraman SS, Rayhan DJ, Hazany S, Kolodney MS: Mutational Landscape of Basal Cell Carcinomas by Whole-Exome Sequencing. J Invest Dermatol. 2014; 134: 213-220. doi: 10.1038/jid.2013.276 PMID: 23774526
26. Saunders CT, Wong WS, Swamy S, Becq J, Murray LJ, Cheetham RK: Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics. 2012; 28: 1811-1817. doi: 10.1093/bioinformatics/bts271 PMID: 22581179
27. Marioni JC, Thorne NP, Tavare S: BioHMM: a heterogeneous hidden Markov model for segmenting array CGH data. Bioinformatics. 2006; 22: 1144-1146. PMID: 16533818
28. Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013; 497: 67-73. doi: 10.1038/nature12113 PMID: 23636398
29. The Cancer Genome Atlas Network: Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012; 487: 330-337. doi: 10.1038/nature11252 PMID: 22810696
30. Wang K, Singh D, Zeng Z, Coleman SJ, Huang Y, Savich GL, et al. MapSplice: accurate mapping of RNA-seq reads for splice junction discovery. Nucleic Acids Res. 2010; 38: e178. doi: 10.1093/nar/gkq622 PMID: 20802226
31. Wilkerson MD, Cabanski CR, Sun W, Hoadley KA, Walter V, Mose LE, et al. Integrated RNA and DNA sequencing improves mutation detection in low purity tumors. Nucleic Acids Res. 2014; 42: e107. doi: 10.1093/nar/gku489 PMID: 24970867
32. Wilkerson MD, Yin X, Walter V, Zhao N, Cabanski CR, Hayward MC, et al. Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylation. PLoS One. 2012; 7: e36530. doi: 10.1371/journal.pone.0036530 PMID: 22590557
33. Nair KR: Table of Confidence Interval for the Median in Samples from Any Continuous Population. Sankhya 1940, 4:551-558.
34. Bansal V: A statistical method for the detection of variants from next-generation resequencing of DNA pools. Bioinformatics. 2010; 26: i318-324. doi: 10.1093/bioinformatics/btq214 PMID: 20529923
35. Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013; 31: 213-219. doi: 10.1038/nbt.2514 PMID: 23396013
36. Gremer L, Merbitz-Zahradnik T, Dvorsky R, Cirstea IC, Kratz CP, Zenker M, et al. Germline KRAS mutations cause aberrant biochemical and physical properties leading to developmental disorders. Hum Mutat. 2011; 32: 33-43. doi: 10.1002/humu.21377 PMID: 20949621
37. Anderson SM: Laboratory methods for KRAS mutation analysis. Expert Rev Mol Diagn. 2011; 11: 635-642. doi: 10.1586/erm.11.42 PMID: 21745016
38. Tsiatis AC, Norris-Kirby A, Rich RG, Hafez MJ, Gocke CD, Eshleman JR, et al. Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications. J Mol Diagn. 2010; 12: 425-432. doi: 10.2353/jmoldx.2010.090188 PMID: 20431034
39. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001; 29: 308-311. PMID: 11125122
40. Chiogna M, Massa MS, Risso D, Romualdi C. A comparison on effects of normalizations in the detection of differentially expressed genes. BMC Bioinformatics. 2009; 10: 61. doi: 10.1186/1471-2105-10-61 PMID: 19216778
41. Tembe WD, Pond SJ, Legendre C, Chuang HY, Liang WS, Kim NE, et al. Open-access synthetic spike-in mRNA-seq data for cancer gene fusions. BMC Genomics. 2014; 15: 824. doi: 10.1186/1471-2164-15-824 PMID: 25266161
42. Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD, Lin L, et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 2012; 22: 568-576. doi: 10.1101/gr.129684.111 PMID: 22300766
43. Govindan R, Ding L, Griffith M, Subramanian J, Dees ND, Kanchi KL, et al. Genomic landscape of nonsmall cell lung cancer in smokers and never-smokers. Cell. 2012; 150: 1121-1134. doi: 10.1016/j.cell.2012.08.024 PMID: 22980976
44. The Cancer Genome Atlas Network: Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012; 489: 519-525. doi: 10.1038/nature11404 PMID: 22960745
45. Imielinski M, Berger AH, Hammerman PS, Hernandez B, Pugh TJ, Hodis E, et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell. 2012; 150: 1107-1120. doi: 10.1016/j.cell.2012.08.029 PMID: 22980975
46. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010; 7: 248-249. doi: 10.1038/nmeth0410-248 PMID: 20354512
47. Foreman AK, Lee K, Evans JP: The NCGENES project: exploring the new world of genome sequencing. N C Med J. 2013; 74: 500-504. PMID: 24316776
48. Iwakawa R, Takenaka M, Kohno T, Shimada Y, Totoki Y, Shibata T, et al. Genome-wide identification of genes with amplification and/or fusion in small cell lung cancer. Genes Chromosomes Cancer. 2013; 52: 802-816. doi: 10.1002/gcc.22076 PMID: 23716474
49. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010; 463: 899-905. doi: 10.1038/nature08822 PMID: 20164920
50. Singh A, Misra V, Thimmulappa RK, Lee H, Ames S, Hoque MO, et al. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med. 2006; 3: e420. PMID: 17020408
51. Altimari A, de Biase D, De Maglio G, Gruppioni E, Capizzi E, Degiovanni A, et al. 454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded samples. Onco Targets Ther. 2013; 6: 1057-1064. doi: 10.2147/OTT.S42369 PMID: 23950653
52. Tuononen K, Maki-Nevala S, Sarhadi VK, Wirtanen A, Ronty M, Salmenkivi K, et al. Comparison of targeted next-generation sequencing (NGS) and real-time PCR in the detection of EGFR, KRAS, and BRAF mutations on formalin-fixed, paraffin-embedded tumor material of non-small cell lung carcinoma-superiority of NGS. Genes Chromosomes Cancer. 2013; 52: 503-511. doi: 10.1002/gcc.22047 PMID: 23362162
53. Sims D, Sudbery I, Ilott NE, Heger A, Ponting CP: Sequencing depth and coverage: key considerations in genomic analyses. Nat Rev Genet. 2014; 15: 121-132. doi: 10.1038/nrg3642 PMID: 24434847
54. Ajay SS, Parker SC, Abaan HO, Fajardo KV, Margulies EH: Accurate and comprehensive sequencing of personal genomes. Genome Res 2011, 21:1498-1505. doi: 10.1101/gr.123638.111 PMID: 21771779
55. Stratton MR, Campbell PJ, Futreal PA: The cancer genome. Nature. 2009; 458: 719-724. doi: 10.1038/nature07943 PMID: 19360079
56. Gnad F, Baucom A, Mukhyala K, Manning G, Zhang Z. Assessment of computational methods for predicting the effects of missense mutations in human cancers. BMC Genomics. 2013; 14 Suppl 3: S7. doi: 10.1186/1471-2164-14-S3-S7 PMID: 23819521
57. Zack TI, Schumacher SE, Carter SL, Cherniack AD, Saksena G, Tabak B, et al. Pan-cancer patterns of somatic copy number alteration. Nat Genet. 2013; 45: 1134-1140. doi: 10.1038/ng.2760 PMID: 24071852
58. Duan J, Zhang JG, Deng HW, Wang YP: Comparative studies of copy number variation detection methods for next-generation sequencing technologies. PLOS ONE. 2013; 8: e59128. doi: 10.1371/journal.pone.0059128 PMID: 23527109
59. Guo Y, Sheng Q, Samuels DC, Lehmann B, Bauer JA, Pietenpol J, et al. Comparative study of exome copy number variation estimation tools using array comparative genomic hybridization as control. Biomed Res Int. 2013; 2013: 915636. doi: 10.1155/2013/915636 PMID: 24303503
60. Lin Y, Li J, Shen H, Zhang L, Papasian CJ, Deng HW: Comparative studies of de novo assembly tools for next-generation sequencing technologies. Bioinformatics. 2011; 27: 2031-2037. doi: 10.1093/bioinformatics/btr319 PMID: 21636596
61. Yi ES, Chung JH, Kulig K, Kerr KM: Detection of anaplastic lymphoma kinase (ALK) gene rearrangement in non-small cell lung cancer and related issues in ALK inhibitor therapy: a literature review. Mol Diagn Ther. 2012; 16: 143-150. doi: 10.2165/11632830-000000000-00000 PMID: 22506598
62. Lee SE, Lee B, Hong M, Song JY, Jung K, Lira ME, et al. Comprehensive analysis of RET and ROS1 rearrangement in lung adenocarcinoma. Mod Pathol. 2015; 28: 468-479. doi: 10.1038/modpathol.2014.107 PMID: 25234288